Login
$ALLR
$0.92 +$0.05 (5.74%) Close

Ownership

13F as of Q2 2026 · 15.9M shares outstanding

Who owns ALLR?

By type of holder
Institutions 0.0% Insiders 7.9% Everyone else 92.1%
Concentration Top 6 holders own 7.9%
Jensen Thomas 3.8% · Epshinsky Alexander 2.1%
Institutional ownership
0.0%
0.0 pts vs last qtr
Institutional holders
0
0 vs last qtr
Net shares bought
0
by institutions in Q2 2026
New / sold out
0 / 0
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

No 13F manager has reported this stock in the last 8 quarters.

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026

None.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Allarity Therapeutics Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2022–FY2023
+29154.2%
+29154.20% a year
Each share's claim on the business
−99.7%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $1.82M
over 2 fiscal years
Diluted shares, split-adjusted
18.5K2.8M5.6M2022: 19.1K shares'222023: 5.6M shares'23
Buybacks Stock-based comp
$0$876.0K$1.8M2022 buybacks: $02022 stock comp: $1.8M'222023 buybacks: $02023 stock comp: $71.0K'23

How patient are the owners?

No 13F manager reports holding ALLR.

Super Investors

Investment managers reporting ALLR on Form 13F
No 13F manager reports holding ALLR yet.

Institutional Funds

Mutual funds and ETFs reporting ALLR on Form N-PORT; together they hold 0.6% of the company
FE
Fidelity Concord Street Trust
Position value
$18.3K
% of company
0.63%
% of the fund
0.00%
As of
August 31, 2024

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
JT
Jensen Thomas
Insider
Shares
596.7K
% of company
3.75%
Change vs last qtr
—
Held since
—
EA
Epshinsky Alexander
Insider
Shares
340.2K
% of company
2.14%
Change vs last qtr
—
Held since
—

4 more holders behind a free account

See every insider and 5%+ holder of Allarity Therapeutics Inc.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support